The mechanism of inhibition by salicylate of the pentose phosphate pathway in the human red cell
- 1 February 1967
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 19 (2), 108-113
- https://doi.org/10.1111/j.2042-7158.1967.tb08045.x
Abstract
Salicylate inhibits the pentose phosphate pathway of glucose metabolism in human red cell haemolysates. The site of inhibition is concerned with glucose 6-phosphate and 6-phosphogluconate dehydrogenases and the mechanism of inhibition involves competition with nadp.This publication has 9 references indexed in Scilit:
- Effects of salicylate and γ-resorcylate (2:6-dihydroxybenzoate) on pathways of glucose metabolism in the human red cellBiochemical Pharmacology, 1966
- Inhibition of Dehydrogenases by SalicylateNature, 1964
- ERYTHROCYTE METABOLISM. V. LEVELS OF GLYCOLYTIC ENZYMES AND REGULATION OF GLYCOLYSIS*JCI Insight, 1962
- Lipid synthesis by human leucocytes in vitroBiochemical Journal, 1960
- The oxidative pentose phosphate cycle. V. Complete oxidation of glucose 6-phosphate in a reconstructed system of the oxidative pentose phosphate cycleArchives of Biochemistry and Biophysics, 1959
- Human Red Cell Glycolytic IntermediatesJournal of Biological Chemistry, 1959
- [42] Glucose-6-phosphate dehydrogenase 6-phosphogluconic dehydrogenaseMethods in Enzymology, 1955
- THE INHIBITION OF ARGINASE BY AMINO ACIDSPublished by Elsevier ,1945